Literature DB >> 27393601

Natural history of diseases: Statistical designs and issues.

Nicholas P Jewell1.   

Abstract

Understanding the natural history of a disease is an important prerequisite for designing studies that assess the impact of interventions, both chemotherapeutic and environmental, on the initiation and expression of the condition. Identification of biomarkers that mark disease progression may provide important indicators for drug targets and surrogate outcomes for clinical trials. However, collecting and visualizing data on natural history is challenging, in part, because disease processes are complex and evolve in different chronological periods for different subjects. Various epidemiological designs are used to elucidate components of the natural history process. We briefly discuss statistical issues, limitations, and challenges associated with various epidemiological designs.
© 2016 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Year:  2016        PMID: 27393601      PMCID: PMC5017909          DOI: 10.1002/cpt.423

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  43 in total

1.  Years of potential life lost (YPLL)--what does it measure?

Authors:  J W Gardner; J S Sanborn
Journal:  Epidemiology       Date:  1990-07       Impact factor: 4.822

2.  Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims.

Authors:  Brenda F Kurland; Laura L Johnson; Brian L Egleston; Paula H Diehr
Journal:  Stat Sci       Date:  2009       Impact factor: 2.901

3.  Lead time gained by diagnostic screening for breast cancer.

Authors:  G B Hutchison; S Shapiro
Journal:  J Natl Cancer Inst       Date:  1968-09       Impact factor: 13.506

4.  Re: Long-term survival and mortality in prostate cancer treated with noncurative intent.

Authors:  A Abrahamsson; H O Adami; A Taube; K Kim; M Zelen; M Kulldorff
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

5.  Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies.

Authors:  W W Piegorsch; C R Weinberg; J A Taylor
Journal:  Stat Med       Date:  1994-01-30       Impact factor: 2.373

6.  Modeling the effect of Alzheimer's disease on mortality.

Authors:  Elizabeth Johnson; Ron Brookmeyer; Kathryn Ziegler-Graham
Journal:  Int J Biostat       Date:  2007       Impact factor: 0.968

7.  A population-based study of the usefulness of screening for neuroblastoma.

Authors:  W G Woods; M Tuchman; L L Robison; M Bernstein; J M Leclerc; L C Brisson; J Brossard; G Hill; J Shuster; R Luepker; T Byrne; S Weitzman; G Bunin; B Lemieux
Journal:  Lancet       Date:  1996 Dec 21-28       Impact factor: 79.321

Review 8.  Long-term survival and mortality in prostate cancer treated with noncurative intent.

Authors:  G Aus; J Hugosson; L Norlén
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

9.  Statistical models for prevalent cohort data.

Authors:  M C Wang; R Brookmeyer; N P Jewell
Journal:  Biometrics       Date:  1993-03       Impact factor: 2.571

10.  Identification and forecasting in mortality models.

Authors:  Bent Nielsen; Jens P Nielsen
Journal:  ScientificWorldJournal       Date:  2014-06-02
View more
  12 in total

1.  Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS).

Authors:  A Amouzegar; M Dehghani; H Abdi; L Mehran; S Masoumi; F Azizi
Journal:  J Endocrinol Invest       Date:  2022-08-04       Impact factor: 5.467

2.  Study on Dynamic Progression and Risk Assessment of Metabolic Syndrome Based on Multi-State Markov Model.

Authors:  Jaina Razbek; Yan Zhang; Wen-Jun Xia; Wan-Ting Xu; De-Yang Li; Zhe Yin; Ming-Qin Cao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-16       Impact factor: 3.249

3.  Early Report on the Impact of COVID-19 Outbreak in Neurosurgical Practice Among Members of the Latin American Federation of Neurosurgical Societies.

Authors:  José Antonio Soriano Sánchez; Tito Arcadio Perilla Cepeda; Marcelo Zenteno; Alvaro Campero; Claudio Yampolsky; Mauro Loyo Varela; Manuel Eduardo Soto García; José Alberto Israel Romero Rangel
Journal:  World Neurosurg       Date:  2020-05-07       Impact factor: 2.104

4.  Exploring the usefulness of Lexis diagrams for quality improvement.

Authors:  Sara Dahlin
Journal:  BMC Med Inform Decis Mak       Date:  2020-01-08       Impact factor: 2.796

Review 5.  The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review.

Authors:  Shelagh M Szabo; Renna M Salhany; Alison Deighton; Meagan Harwood; Jean Mah; Katherine L Gooch
Journal:  Orphanet J Rare Dis       Date:  2021-05-22       Impact factor: 4.123

6.  Predicting the natural history of metabolic syndrome with a Markov-system dynamic model: a novel approach.

Authors:  Abbas Rezaianzadeh; Esmaeil Khedmati Morasae; Davood Khalili; Mozhgan Seif; Ehsan Bahramali; Fereidoun Azizi; Pezhman Bagheri
Journal:  BMC Med Res Methodol       Date:  2021-11-27       Impact factor: 4.615

Review 7.  Epilepsy Genetics and Precision Medicine in Adults: A New Landscape for Developmental and Epileptic Encephalopathies.

Authors:  Álvaro Beltrán-Corbellini; Ángel Aledo-Serrano; Rikke S Møller; Eduardo Pérez-Palma; Irene García-Morales; Rafael Toledano; Antonio Gil-Nagel
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

8.  Periodontal disease prevalence, extent, and risk associations in untreated individuals.

Authors:  Yasmine N Alawaji; Abdulsalam Alshammari; Nesrine Mostafa; Ricardo M Carvalho; Jolanta Aleksejuniene
Journal:  Clin Exp Dent Res       Date:  2022-01-10

9.  DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.

Authors:  Aiysha Chaudhry; Alkyoni Anthanasiou-Fragkouli; Henry Houlden
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

10.  A unified framework of demographic time.

Authors:  Tim Riffe; Jonas Schöley; Francisco Villavicencio
Journal:  Genus       Date:  2017-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.